TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2903762

Group type: EXPERIMENTAL
Intervention: Mifentidine 2.5 mg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Mifentidine 5 mg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Mifentidine 10 mg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Mifentidine 20 mg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Mifentidine 10 mg (multiple dosing for 14 days)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Mifentidine 20 mg (multiple dosing for 14 days)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Mifentidine (both doses)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 30730813

Group type: EXPERIMENTAL
Intervention: EX + SIT (sitting 1 h, moderate-intensity walking 30 min, uninterrupted sitting 6.5 h)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: EX + BR (sitting 1 h, moderate-intensity walking 30 min, sitting 6.5 h with 3 min light-intensity walking every 30 min)
Number of subjects: 12

Group type: COMPARATOR
Intervention: SIT (prolonged sitting 8 h, control)
Number of subjects: 12
Study: 28806917

Group type: EXPERIMENTAL
Intervention: My Tools 4 Care (MT4C)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Educational control group
Number of subjects: 180
Study: 25003426

Group type: EXPERIMENTAL
Intervention: TCL releasing only (Group 1)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: TCL and distal forearm fascia releasing (Group 2)
Number of subjects: 113
Study: 23865657

Group type: EXPERIMENTAL
Intervention: Daily calorie recommendations
Number of subjects: 1121

Group type: EXPERIMENTAL
Intervention: Per-meal calorie recommendations
Number of subjects: 1121

Group type: COMPARATOR
Intervention: No calorie recommendations
Number of subjects: 1121
Study: 21360507

Group type: EXPERIMENTAL
Intervention: Modified-release sildenafil 200 mg once daily for 25 days
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Modified-release sildenafil
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Modified-release sildenafil and Placebo
Number of subjects: 57
Study: 19422140

Group type: EXPERIMENTAL
Intervention: Chromium picolinate (CrPic) at 1000 microg/day
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 16417639

Group type: EXPERIMENTAL
Intervention: Sleeping with dentures
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sleeping without dentures
Number of subjects: 48
Study: 15246645

Group type: EXPERIMENTAL
Intervention: Implantable Loop Recorder (ILR) - Reveal Plus ILR
Number of subjects: 201

Group type: COMPARATOR
Intervention: Conventional investigation
Number of subjects: 201
Study: 12575565

Group type: EXPERIMENTAL
Intervention: Xianlong Capsule (XLC)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Hydergine
Number of subjects: 68
Study: 9573428

Group type: EXPERIMENTAL
Intervention: Told-alcohol condition (alcohol-dependent subjects)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Told-alcohol condition (moderately dependent alcoholics)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Told-alcohol condition (severely dependent alcoholics)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Told-alcohol condition (social drinkers)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Told-soft drinks condition (not specified for alcoholics)
Number of subjects: 30
Study: 7838516

Group type: EXPERIMENTAL
Intervention: Doxycycline (200 mg on the first day, then 100 mg for 6.8 days)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Ofloxacin (100 mg twice a day for 8.0 days)
Number of subjects: 194
Study: 3283356

Group type: EXPERIMENTAL
Intervention: 1000 mg IV-methylprednisolone
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 320 mg IV-methylprednisolone
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 320 mg IM-methylprednisolone
Number of subjects: 29
Study: 31654276

Group type: EXPERIMENTAL
Intervention: Evolife intervention (12 weeks' access to the Evolife website, face-to-face introductory session, and a pedometer)
Number of subjects: 60

Group type: COMPARATOR
Intervention: NHS online health resources (control condition with face-to-face introductory session)
Number of subjects: 60
Study: 28077584

Group type: EXPERIMENTAL
Intervention: EV71 vaccine
Number of subjects: 10245

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10245
Study: 26018947

Group type: EXPERIMENTAL
Intervention: EA (Electroacupuncture)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham EA
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care (usual care with antiemetics)
Number of subjects: 60
Study: 24554949

Group type: EXPERIMENTAL
Intervention: Breast feeding
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control
Number of subjects: 96
Study: 21851022

Group type: EXPERIMENTAL
Intervention: Open lung maneuver
Number of subjects: 81

Group type: COMPARATOR
Intervention: Standard respiratory support (control)
Number of subjects: 81
Study: 19398602

Group type: EXPERIMENTAL
Intervention: LXR-623
Number of subjects: 0
Study: 17201540

Group type: EXPERIMENTAL
Intervention: Attitude clarity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attitude correctness
Number of subjects: 0
Study: 15134764

Group type: EXPERIMENTAL
Intervention: Highly familiar symbols
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Moderately familiar symbols
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Highly unfamiliar symbols
Number of subjects: 0
Study: 11842449

Group type: EXPERIMENTAL
Intervention: Individualized psychocognitive educational intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 60
Study: 9219316

Group type: EXPERIMENTAL
Intervention: meloxicam 7.5 mg
Number of subjects: 9000

Group type: EXPERIMENTAL
Intervention: meloxicam 7.5 mg and 15 mg
Number of subjects: 9000
Study: 7932124

Group type: EXPERIMENTAL
Intervention: Topical diclofenac sodium 0.1% (Voltaren) solution
Number of subjects: 65

Group type: COMPARATOR
Intervention: Tears Naturale (control group)
Number of subjects: 65
Study: 2905149

Group type: EXPERIMENTAL
Intervention: Propranolol (40, 80 and 160 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Atenolol (50 and 100 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Oxazepam (15 mg)
Number of subjects: 12
Study: 26987871

Group type: EXPERIMENTAL
Intervention: Exercise intervention (individualized training programmes aiming for ≥90 min of moderate-to-vigorous activity each week)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 31

Group type: COMPARATOR
Intervention: Treatment as usual (control group, n=7)
Number of subjects: 31
Study: 27404007

Group type: EXPERIMENTAL
Intervention: Conventional SMS campaign
Number of subjects: 2312

Group type: EXPERIMENTAL
Intervention: Tailored SMS campaign
Number of subjects: 2312

Group type: COMPARATOR
Intervention: Control group (routine SMS counseling)
Number of subjects: 2312
Study: 24325147

Group type: EXPERIMENTAL
Intervention: 100 mg simethicone suspension in 5 mL water
Number of subjects: 1849

Group type: EXPERIMENTAL
Intervention: 100 mg simethicone suspension in 100 mL water
Number of subjects: 1849

Group type: EXPERIMENTAL
Intervention: 100 mg simethicone suspension in 100 mL water containing 200 mg N-acetylcysteine
Number of subjects: 1849

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 1849
Study: 22732860

Group type: EXPERIMENTAL
Intervention: Popliteal block
Number of subjects: 51

Group type: COMPARATOR
Intervention: General anesthesia (GETA)
Number of subjects: 51
Study: 19748613

Group type: EXPERIMENTAL
Intervention: Cotton‐tipped applicator primed gauze pledgetting (CTGP)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Endoscopic‐guided aerosolized spray (EGAS)
Number of subjects: 240
Study: 18406179

Group type: EXPERIMENTAL
Intervention: Heparin alone (H)
Number of subjects: 2107

Group type: COMPARATOR
Intervention: Heparin reversed with protamine (H+P)
Number of subjects: 2107
Study: 16199404

Group type: EXPERIMENTAL
Intervention: STAR training program (two 4-hr workshops, four individualized on-site consultations, three leadership sessions)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: STAR training program
Number of subjects: 114
Study: 12840647

Group type: EXPERIMENTAL
Intervention: Slow weight training
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Explosive weight training
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (usual training)
Number of subjects: 38
Study: 10563141

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 90
Study: 10186680

Group type: EXPERIMENTAL
Intervention: Physician reminder letter combined with telephone counseling from a health educator
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Intervention costs
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Intervention process
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Intervention cost reduction strategies
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Women’s comfort level
Number of subjects: 304
Study: 1493628

Group type: EXPERIMENTAL
Intervention: Unipolar diathermy
Number of subjects: 150

Group type: COMPARATOR
Intervention: Ligation for haemostasis
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Unipolar diathermy and Ligation
Number of subjects: 150
Study: 3887548

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 30501928

Group type: EXPERIMENTAL
Intervention: IOLMaster
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: SlitLamp
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: ImageJ
Number of subjects: 61

Group type: COMPARATOR
Intervention: SlitLamp vs ImageJ
Number of subjects: 61
Study: 29653686

Group type: EXPERIMENTAL
Intervention: Pegvaliase 20 mg/day
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Pegvaliase 40 mg/day
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Pegvaliase (varied doses from 5 mg/day to 60 mg/day)
Number of subjects: 261

Group type: EXPERIMENTAL
Intervention: Pegvaliase treatment
Number of subjects: 261
Study: 24861503

Group type: EXPERIMENTAL
Intervention: Ezetimibe-Simvastatin (E-S) 10/40 mg
Number of subjects: 128

Group type: COMPARATOR
Intervention: High dose Rosuvastatin 20 mg
Number of subjects: 128
Study: 21704482

Group type: EXPERIMENTAL
Intervention: Gender-specific total knee arthroplasty
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional unisex total knee arthroplasty
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Patient subjective preferences
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Radiologic results
Number of subjects: 50
Study: 20813979

Group type: COMPARATOR
Intervention: Normoxia (0.21 O2 fraction, 98% arterial O2 saturation)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Mild hypoxia (0.16 O2 fraction, 93% arterial O2 saturation)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Moderate hypoxia (0.13 O2 fraction, 85% arterial O2 saturation)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Severe hypoxia (0.10 O2 fraction, 74% arterial O2 saturation)
Number of subjects: 11
Study: 16875813

Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MF) delivered by HFA‐227 metered dose inhaler (MDI) 400 microg bid
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MF) delivered by HFA‐227 metered dose inhaler (MDI) 800 microg bid
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MF) in the open-label phase
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MF) treatment
Number of subjects: 123
Study: 16261774

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 60
Study: 11884789

Group type: COMPARATOR
Intervention: 75 ml of contrast material (Ioversol 320) only (Group A)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: 75 ml of contrast medium pushed with 6 ml saline (Group B)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: 75 ml of contrast medium pushed with 12 ml saline (Group C)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: 75 ml of contrast medium pushed with 25 ml saline (Group D)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: 75 ml of contrast medium pushed with 50 ml saline (Group E)
Number of subjects: 125
Study: 10567802

Group type: COMPARATOR
Intervention: Nissen fundoplication with posterior cruroplasty (n = 16)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Nissen cruroplasty with onlay of polytetrafluoroethylene (PTFE) mesh (n = 15)
Number of subjects: 31
Study: 7916913

Group type: EXPERIMENTAL
Intervention: Buprenorphine (1 mg, intramuscularly)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 2515016

Group type: EXPERIMENTAL
Intervention: Tiopronin (T)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Gold thiosulphate (GTS)
Number of subjects: 200
Study: 30872104

Group type: EXPERIMENTAL
Intervention: Oral viscous budesonide (OVB) 1 mg/4 mL twice daily
Number of subjects: 111

Group type: COMPARATOR
Intervention: Fluticasone MDI 880 μg twice daily
Number of subjects: 111
Study: 28656805

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH), single dose, 10 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 22
Study: 26463044

Group type: EXPERIMENTAL
Intervention: Information suggesting that other children had eaten a large amount of carrots
Number of subjects: 143

Group type: COMPARATOR
Intervention: No carrots
Number of subjects: 143

Group type: COMPARATOR
Intervention: Control information
Number of subjects: 143
Study: 23323043

Group type: EXPERIMENTAL
Intervention: Lower kilovoltage potential (kVp) (A)
Number of subjects: 4500

Group type: EXPERIMENTAL
Intervention: Intermediate kVp (B)
Number of subjects: 4500

Group type: EXPERIMENTAL
Intervention: Higher kVp (C)
Number of subjects: 4500

Group type: COMPARATOR
Intervention: Fixed high kVp group (controls)
Number of subjects: 4500
Study: 20851057

Group type: EXPERIMENTAL
Intervention: Collaborative care intervention (CCI)
Number of subjects: 362

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 362
Study: 18076218

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate 150 mg twice daily for 6 days and once on day 7
Number of subjects: 36

Group type: COMPARATOR
Intervention: Dabigatran etexilate with pantoprazole 40 mg twice daily starting 2 days prior to dabigatran administration
Number of subjects: 36
Study: 16929431

Group type: EXPERIMENTAL
Intervention: Gothenburg osseointegrated titanium (GOT) system
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cemented Spectron femoral component and cementless Trilogy cup
Number of subjects: 40
Study: 14559386

Group type: EXPERIMENTAL
Intervention: Vaginally administered allopregnanolone gel during the last 10 days of the second cycle (group 1)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Vaginally administered allopregnanolone gel during the last 10 days of each cycle (group 2)
Number of subjects: 13
Study: 11136298

Group type: EXPERIMENTAL
Intervention: Rifampicin 600 mg once daily for 5 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 8633255

Group type: EXPERIMENTAL
Intervention: Radical surgery
Number of subjects: 176

Group type: COMPARATOR
Intervention: Definitive radiotherapy (60 Gy)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Resection plus postoperative irradiation (45 Gy)
Number of subjects: 176
Study: 8404160

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 41

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 41
Study: 3533126

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (84 mg total over 4 days, starting with 24 mg 2 hours after surgery)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Paracetamol (1 g at 2, 6, and 9 hours after surgery, then 500 mg four times daily for the next 2 days)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 24
Study: 30127197

Group type: EXPERIMENTAL
Intervention: Sectional matrix band system
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Circumferential matrix band system
Number of subjects: 1200
Study: 25758633

Group type: EXPERIMENTAL
Intervention: Empowerment program (3-stage training plan)
Number of subjects: 80
Study: 24833780

Group type: EXPERIMENTAL
Intervention: Whey protein + multimode exercise training (PRISE)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Whey protein + resistance training (P + RT)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Whey protein only (P)
Number of subjects: 79
Study: 22800470

Group type: EXPERIMENTAL
Intervention: Green tea
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Black tea
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Caffeinated water
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 20615853

Group type: EXPERIMENTAL
Intervention: Manual Acupuncture (MA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) 10 Hz
Number of subjects: 40

Group type: COMPARATOR
Intervention: Electroacupuncture (EA) 2 Hz
Number of subjects: 40

Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 40
Study: 17765272

Group type: EXPERIMENTAL
Intervention: Apomorphine (5 microg/kg sc)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 15953577

Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 35

Group type: COMPARATOR
Intervention: Gatifloxacin
Number of subjects: 35
Study: 12447861

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 51

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 51
Study: 10599601

Group type: EXPERIMENTAL
Intervention: Outpatient geriatric assessment with an intervention to increase adherence
Number of subjects: 351

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 351
Study: 7592202

Group type: EXPERIMENTAL
Intervention: Lesser Mueller maneuver
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Greater Mueller maneuver
Number of subjects: 16
Study: 1850576

Group type: EXPERIMENTAL
Intervention: Barley foods
Number of subjects: 21

Group type: COMPARATOR
Intervention: Wheat foods
Number of subjects: 21
Study: 7197493

Group type: EXPERIMENTAL
Intervention: Isobaric 0.5% tetracaine spinal anesthesia
Number of subjects: 98

Group type: COMPARATOR
Intervention: Hyperbaric 0.5% tetracaine spinal anesthesia
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Isobaric tetracaine with dextrose
Number of subjects: 98

Group type: COMPARATOR
Intervention: Isobaric tetracaine without dextrose
Number of subjects: 98
Study: 29696833

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg twice daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg twice daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg twice daily (in ORAL Standard)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg twice daily (in ORAL Standard)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (MTX or adalimumab)
Number of subjects: 0
Study: 29562206

Group type: EXPERIMENTAL
Intervention: Semipermeable membrane (Tegaderm™)
Number of subjects: 164

Group type: COMPARATOR
Intervention: No membrane (Control)
Number of subjects: 164
Study: 27029546

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Systemic Therapy (ST)
Number of subjects: 32
Study: 24363128

Group type: EXPERIMENTAL
Intervention: CyA MEPC 2-3 mg/kg BW once a day before breakfast
Number of subjects: 48

Group type: COMPARATOR
Intervention: CyA MEPC 1.5 mg/kg BW twice a day before meals
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: CyA MEPC 2-3 mg/kg BW once a day (C2 ≥600 ng/mL)
Number of subjects: 48

Group type: COMPARATOR
Intervention: CyA MEPC 1.5 mg/kg BW twice a day (C2 ≥600 ng/mL)
Number of subjects: 48
Study: 20886571

Group type: EXPERIMENTAL
Intervention: Standard-dose pregabalin/tolterodine ER (150 mg BID/4 mg QD)
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Pregabalin alone (150 mg BID)
Number of subjects: 519

Group type: COMPARATOR
Intervention: Tolterodine ER alone (4 mg QD)
Number of subjects: 519

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Low-dose pregabalin/tolterodine ER (75 mg BID/2 mg QD)
Number of subjects: 519
Study: 19723121

Group type: EXPERIMENTAL
Intervention: 20 mg tonabersat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 40 mg tonabersat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 50 mg sumatriptan (positive control)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17368154

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (10 mg daily, 5 mg for children younger than 12 months) for mean 484.7 days
Number of subjects: 42546

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42546
Study: 15129941

Group type: EXPERIMENTAL
Intervention: Adenoidectomy or adenotonsillectomy
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (children without nasal complaints)
Number of subjects: 35
Study: 12013585

Group type: EXPERIMENTAL
Intervention: Dysport 500 units
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Dysport 500 units (open phase treatment)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo (open phase treatment)
Number of subjects: 68
Study: 9141920

Group type: EXPERIMENTAL
Intervention: tranexamic acid (100 mg/kg, followed by 10 mg.kg‐1.h‐1)
Number of subjects: 41

Group type: COMPARATOR
Intervention: saline placebo
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: tranexamic acid
Number of subjects: 41
Study: 8201089

Group type: EXPERIMENTAL
Intervention: Haemofiltration and/or haemodialysis (Group HD)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Fluid infusion alone (Group non-HD)
Number of subjects: 26
Study: 3322955

Group type: COMPARATOR
Intervention: Cimetidine 800 mg daily
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg plus pirenzepine 100 mg daily
Number of subjects: 131
Study: 29331706

Group type: EXPERIMENTAL
Intervention: CAU plus the Internet intervention Deprexis
Number of subjects: 509

Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 509